Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study

• Main Authors: Michael Boettcher (Author), Gerd Mikus (Author), Dietmar Trenk (Author), Hans‐Dirk Düngen (Author), Frank Donath (Author), Nikos Werner (Author), Mahir Karakas (Author), Nina Besche (Author), Dominik Schulz‐Burck (Author), Mireille Gerrits (Author), James Hung (Author), Corina Becker (Author)
• Format: Book
• Published: Wiley, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Vericiguat was developed for the treatment of symptomatic chronic heart failure (HF) in adult patients with reduced ejection fraction who are stabilized after a recent decompensation event. Guidelines recommend long‐acting nitrates, such as isosorbide mononitrate, for angina prophylaxis in...